Skip to main content

Contact Us
Investors & Media

Mission
Medicines & Research
Company
Responsibility
Careers

Update on FORTITUDE-ALS: a Phase 2, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate Efficacy, Safety, and Tolerability of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis

Home
Mission
Medicines & Research
Company
Responsibility
Careers
Updated Privacy Policy
Cookie Policy
Terms of Use

Cytokinetics scientists and collaborators are committed to high scientific and ethical publications standards and are dedicated to providing our science to the medical and scientific community through peer-reviewed journals and medical forums. Our scientific publications (e.g., manuscripts, posters and/or oral presentations that contain data from Cytokinetics-sponsored studies, have Cytokinetics authors, or for which Cytokinetics provides writing and/or editorial assistance) are generally intended for health care professionals.

If you have specific questions or require additional information, please contact Cytokinetics Medical Information at [email protected].

Note: All content provided as is and per applicable permissions; some links provided below redirect to third-party websites that may require a subscription to access publications.